Clinical Trial Update: Pulmonary Interstitial Lymphography in Early Stage Lung Cancer [NA]

View source ↗

Summary

The Stanford University-sponsored trial 'Pulmonary Interstitial Lymphography in Early Stage Lung Cancer' has been terminated. The trial status is TERMINATED wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Mesothelioma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Snippet

Sponsor: Stanford University | Conditions: Lung Cancer, Lung Cancer Non-Small Cell Cancer (NSCLC) | NA | Status: TERMINATED